Lessons learned from COVID-19 pandemic in Italy by Minni, Antonio et al.
  SPECIAL ARTICLE  
Running title: Lessons learned from COVID-19 
Lessons Learned from COVID-19 Pandemic in Italy. A Commentary. 
 
Antonio Minni1, Massimo Ralli1*, Francesca Candelori1, Fabrizio Cialente1, Lucia Ercoli2, Claudio 
Parlapiano3, Antonio Greco1, Marco de Vincentiis4 
1. Department of Sense Organs, Sapienza University of Rome, Rome, Italy 
2. Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy 
3. Department of Clinical Sciences and Internal Medicine, Sapienza University of Rome, Rome 
Italy 
4. Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Rome, Italy 
 
*Corresponding author: Massimo Ralli, Department of Sense Organs, Sapienza University of 
Rome, Viale dell’Università 33, 00168 Rome, Italy. Phone: +390649976808 
E-mail: massimo.ralli@uniroma1.it 
DOI: https://dx.doi.org/10.17305/bjbms.2020.4847 
Submitted: 15 May 2020/Accepted: 16 May 2020 
Conflict of interest statement: The authors declare no conflict of interests 
Sources of Funding: None 
Licence: © The Author(s) (2020). This work is licensed under a Creative Commons Attribution 4.0 
International License 
 
 Article type: Commentary 
 
 
  
Abstract 
Since the COVID-19 outbreak, Italy has been one of the most affected countries in Europe and the 
second for number of deaths. In this commentary, we discuss some lessons that we learned as 
healthcare providers working in a large public hospital during the pandemic, with a special focus on 
the importance of infection containment and early diagnosis, the role of swab, serological tests, home 
isolation and individual protection devices,  and the available therapies and management indications 
to better face a possible new outbreak in the near future. These comments should stimulate a more 
diffused, efficient and efficacious management of COVID-19 patients, also reducing the number of 
accesses to hospital emergency departments and the related spread of the infection.  
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Introduction 
The Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2) pandemic had dramatic 
effects on most countries worldwide (1-3); Italy is one of the most affected countries in Europe and 
the second for number of deaths (4-6).  
The pandemic also severely affected the population and, especially, healthcare providers in many 
disciplines including general practitioners, anesthesiologists, otolaryngologists and infectious 
medicine specialists (7, 8). In this commentary, we discuss some lessons that we learned as healthcare 
providers working in a large public hospital during the pandemic, with a special focus on the 
importance of infection containment and early diagnosis, the role of swab, serological tests, home 
isolation and individual protection devices,  and the available therapies and management indications 
to better face a possible new outbreak in the near future. 
 
First lesson: Infection containment and early diagnosis. 
Reports from the last century on the pandemic of 1918 stressed the importance of isolation and home 
therapy (9). This recommendation is also topical during this pandemic. In fact, conveying and 
directing affected people towards hospitals, that became the first places of the spread of the infection, 
can be a serious mistake (10). 
Instead, it is necessary to empower territorial medicine allowing general practitioners to go to the 
patients' home with proper personal protective equipment (PPE) to perform SARS-CoV-2 swab at 
home and identify and isolate positive subjects at an early stage. Individual isolation and early 
medical therapy may allow the prevention of severe pulmonary complications that require 
hospitalization and intensive care and limit the spread of the infection (11). 
However, the difficulties and inefficiency of territorial medicine and the scarcity of swabs and PPE, 
especially during the initial phase of the pandemic, have increased the number of COVID-19 positive 
patients admitted to hospitals, contributed to the spread of the infection and to a higher mortality rate 
in the general population and in healthcare personnel (12).  
During the pandemic, many hospital structures appeared inadequate for both the scarcity of intensive 
care units (ICU) beds and the lack of an appropriate number of highly specialized personnel, such as 
anesthesiologists. In addition, the reallocation of personnel to other departments and the merge of 
many units during the pandemic sometimes facilitated spreading the infection among hospital units; 
it was only later understood the importance of identifying structures reserved to COVID-19 patients. 
At this regard, monobloc hospitals experienced more difficulties to predispose separate routes and 
isolate COVID-19 patients compared to structures with separated buildings. This architectural detail 
should be considered in the future, when dedicated hospitals geographically distributed in the urban 
consular peripheral areas should be identified and dedicated to the management of affected patients. 
 
Second lesson: Swab, serological test, home isolation and individual protection devices 
The execution of nasopharyngeal swab for SARS-CoV-2 has been a critical topic in Italy. As of May 
2020, nearly 70 days after the beginning of the lockdown in our country (March 10, 2020), a large 
portion of the healthcare personnel has not performed the swab (5). Specific kits for serological 
testing that identify and quantify Immunoglobulins G and M for SARS-CoV-2 infection are now 
available and should be performed in healthcare workers and – if possible – in the entire population 
(13). In case of serological positivity, a nasopharyngeal swab should be performed, allowing for early 
identification and isolation of potentially positive subjects.  
Home isolation is another important element. Positive individuals should be isolated for a period of 
at least 4 weeks, and swabs should be performed at home at regular intervals to monitor disease 
progression and healing. It is important to understand that – to date – the timing of positivity for 
SARS-CoV-2 immunoglobulins is still unknown and this should be taken into account when declaring 
a patient as “negative” and discharge him from home or hospital isolation (13).  
PPE play a central role in preventing SARS-CoV-2 spread, and their shortage especially in the first 
weeks has been reported (14). Wearing PPE such as masks and gloves outside home, in public places 
or public transports is of utmost importance to prevent contagion and infection spread, as well as the 
generic recommendation of frequently washing hands. Healthcare personnel must be provided with 
complete and adequate PPE, including FFP2 or FFP3 masks, hats, goggles, gloves and full-length 
gowns. Precise safety protocols for dressing and undressing procedures should be followed. 
 
Third lesson: Therapy and management indications 
In the recent months, dozens of drugs and therapeutic protocols have been proposed to treat COVID-
19; however, to date no vaccine and specific therapies have been validated (15). Therapies currently 
used in COVID-19 patients include antibiotics (third-generation macrolides/cephalosporins) and 
corticosteroids; validation of hydroxychloroquine is being sought in the early stages of lung 
involvement; further studies will be necessary for the use of monoclonal inhibitors of the 
inflammatory cascade reaction (16). The use of low molecular weight heparins to cope with some 
dramatic clinical manifestations of COVID-19 infection is now widespread, and studies involving the 
use of fresh plasma from probably immune donors are being validated. In any case, therapies should 
be tailored on individual patient status and clinical conditions (17).  
A territorial-based healthcare structure should provide home assistance to patients; this structure 
should be divided into a centralized operational unit that coordinates medical and paramedical staff, 
and an external operative unit for diagnostic and therapeutic management of patients according to the 
guidelines and the protocol developed (18). The operational center should have an expert doctor in 
contact with the external operative unit, that would be ready to indicate additional therapeutic 
interventions. 
 
Conclusions 
The experience accumulated in the first months of the pandemic suggests that COVID-19 patients 
should be diagnosed and managed at home, especially in the early phases and when clinical conditions 
do not require hospitalization or intensive care. PPE should always be used for individual protection 
and to prevent the spread of the infection. Serological tests should be extensively performed in the 
healthcare and general population; in case of serological positivity, a nasopharyngeal swab should be 
performed for early identification and isolation of infectious subjects. Specific architectural hints in 
hospital construction should be considered to face future pandemics.  
These recommendations would allow a more diffused, efficient and efficacious management of 
COVID-19 patients, also reducing the number of accesses to hospital emergency departments and the 
spread of the infection.  
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